Keywords: belgium, ucb, submits, xyzal, nda, fda, belgian

Belgium's UCB submits Xyzal NDA to FDA

Article | 07 August 2006

Belgian pharmaceutical firm UCB says that it has submitted a New Drug Application for Xyzal (levocetirizine dihydrochloride) an antihistamine product ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

UCB

Go to company listing

Related Drugs

Levocetirizine Dihydrochloride

Xyzal

Go to drug listing